Patent details

Basic Information

Publication number:

EP2305194

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Revoked

Application number:

EP101852408

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

A buprenorphine transdermal patch for use in the treatment of pain for a dosing interval of at least 7 days

French Title of Invention:

Un timbre transdermique comprenant de la buprenorphine pour son utilisation dans le traitement de la douleur pour un interval de dosage d'au moins 7 jours

German Title of Invention:

Transdermales Pflaster mit Buprenorphin zur Verwendung in der Behandlung von Schmerzen für ein Dosierung-Intervall von 7 Tagen

SPC Number:

Dates

Filing date:

24/02/1998

Grant date:

09/05/2012

EP Publication Date:

09/05/2012

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

06/04/2011

EP B1 Publication Date:

09/05/2012

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

24/05/2025

Renunciation date:

Revocation date:

25/07/2017

Annulment date:

Owner

From:

27/05/2016

 

 

Name:

EURO-CELTIQUE S.A.

Address:

1, rue Jean Piret, 2350 Luxembourg, Luxembourg (LU)

Name:

Mundipharma AB

Address:

Mölndalsvägen 26, 412 63 Göteborg, Sweden (SE)

Name:

Mundipharma Laboratories GmbH

Address:

St. Alban-Rheinweg 74, 4020 Basel, Switzerland (CH)

Name:

Mundipharma OY

Address:

Rajatorpantie 41 C, 01640 Vantaa, Finland (FI)

Name:

Mundipharma Pharmaceuticals B.V.

Address:

De Wel 20, 3871 Hoevelaken, Netherlands (NL)

Name:

Mundipharma Pharmaceuticals Limited

Address:

Millbank House Arkle Road Sandyford, Dublin 18, Ireland (IE)

Name:

Napp Pharmaceutical Holdings Limited

Address:

Cambridge Science Park Milton Road, Cambridge CB4 0AB, United Kingdom (GB)

Name:

Norpharma A/S

Address:

Frydenlundsvej 30, 2950 Vedbaek, Denmark (DK)

Agent

Name:

NV GEVERS PATENTS

From:

02/08/2012

Address:

HOLIDAYSTRAAT 5, 1821, DIEGEM - BRUXELLES, Belgium (BE)

To:

Inventor

1

Name:

Goldenheim Paul, D.

Address:

United States (US)

2

Name:

Reder Robert, F.

Address:

United States (US)

3

Name:

Kaiko Robert, F.

Address:

United States (US)

Priority

1

Priority Number:

38919 P

Priority Date:

24/02/1997

Priority Country:

United States (US)

2

Priority Number:

939068

Priority Date:

29/09/1997

Priority Country:

United States (US)

Classification

Main IPC Class:

A61F 13/00;

Publication

Bulletin

Bulletin Heading:

VRV

Bulletin edition number:

2018/02

Publication date:

15/01/2018

Description:

Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates

European Patent Bulletin

Issue number:

201801

Publication date:

03/01/2018

Description:

Revocation of the European patent

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

10/02/2017

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

MDC (HENKEL PATENT)

Filing date	Document type	Number of pages